The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

An episode of the "Joe Rogan Experience" podcast, seen by more than 10 million, appears to have reignited interest in the ...

A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and ...

Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type ...

United Cancer Advocates Network Ireland brings together people currently campaigning for specific cancers to address common ...

Deputy directors at the FDA center that oversees the regulation of cancer drugs plan to leave, adding to a flood of top ...